We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+15.65%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$23.7B
AUM Growth
+$6.7B
(+39%)
Cap. Flow
+$3.87B
Cap. Flow
% of AUM
16.32%
Top 10 Holdings %
Top 10 Hldgs %
42.3%
Holding
1,113
New
41
Increased
800
Reduced
228
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.89B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$702M |
| 3 |
Qualcomm
QCOM
|
+$111M |
| 4 |
Apple
AAPL
|
+$86.9M |
| 5 |
Microsoft
MSFT
|
+$85.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$64.2M |
| 2 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$55.5M |
| 3 |
Intel
INTC
|
+$44M |
| 4 |
Advanced Micro Devices
AMD
|
+$29.1M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$17.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.04% |
| 2 | Financials | 10.33% |
| 3 | Healthcare | 6.19% |
| 4 | Consumer Discretionary | 4.07% |
| 5 | Energy | 2.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
AT&T
T
$159B
| $9.31M | 0.04% |
554,794
+22,211
| +4% | +$351K |
|
302
Beam Therapeutics
BEAM
$2.63B
| $9.25M | 0.04% |
339,717
-424
| -0.1% | -$10.5K |
|
303
Columbia Banking Systems
COLB
$8.84B
| $9.24M | 0.04% |
346,308
+69,875
| +25% | +$1.55M |
|
304
CRISPR Therapeutics
CRSP
$4.73B
| $9.22M | 0.04% |
147,337
-42,050
| -22% | -$2.32M |
|
|
IMGN
305
DELISTED
Immunogen Inc
IMGN
| $9.11M | 0.04% |
307,369
-259,616
| -46% | -$5.17M |
|
306
T. Rowe Price
TROW
$23.9B
| $9.04M | 0.04% |
83,949
+4,369
| +5% | +$435K |
|
307
Deere & Co
DE
$160B
| $8.98M | 0.04% |
22,466
+774
| +4% | +$292K |
|
308
L3Harris
LHX
$51.6B
| $8.94M | 0.04% |
42,443
+1,133
| +3% | +$213K |
|
309
Cigna
CI
$73.7B
| $8.92M | 0.04% |
29,789
-1,098
| -4% | -$321K |
|
310
Kinder Morgan
KMI
$71.7B
| $8.9M | 0.04% |
504,482
-8,112
| -2% | -$138K |
|
311
Axos Financial
AX
$5.77B
| $8.89M | 0.04% |
162,804
+102,704
| +171% | +$4.29M |
|
312
Keysight
KEYS
$54.5B
| $8.83M | 0.04% |
55,506
+8,728
| +19% | +$1.19M |
|
313
Willis Towers Watson
WTW
$31.2B
| $8.83M | 0.04% |
36,609
+1,439
| +4% | +$333K |
|
314
Valley National Bancorp
VLY
$7.9B
| $8.81M | 0.04% |
811,248
+271,264
| +50% | +$2.43M |
|
315
SouthState Bank Corp
SSB
$10.2B
| $8.78M | 0.04% |
103,990
+37,049
| +55% | +$2.73M |
|
316
Syndax Pharmaceuticals
SNDX
$1.69B
| $8.72M | 0.04% |
403,381
+119,257
| +42% | +$1.83M |
|
317
Crinetics Pharmaceuticals
CRNX
$8.84B
| $8.69M | 0.04% |
244,289
+46,548
| +24% | +$1.43M |
|
318
Boston Scientific
BSX
$69.5B
| $8.62M | 0.04% |
149,056
-3,724
| -2% | -$199K |
|
319
Hartford Financial Services
HIG
$38.9B
| $8.57M | 0.04% |
106,611
+3,992
| +4% | +$301K |
|
|
BLD
320
DELISTED
TopBuild
BLD
| $8.57M | 0.04% |
22,891
+4,112
| +22% | +$1.18M |
|
|
APLS
321
DELISTED
Apellis Pharmaceuticals
APLS
| $8.57M | 0.04% |
143,118
-71,043
| -33% | -$3.6M |
|
322
Southern Company
SO
$109B
| $8.53M | 0.04% |
121,676
+10,531
| +9% | +$723K |
|
323
Ardelyx
ARDX
$1.22B
| $8.53M | 0.04% |
1,375,514
+277,620
| +25% | +$1.25M |
|
324
State Street
STT
$50.6B
| $8.47M | 0.04% |
109,392
-2,787
| -2% | -$194K |
|
325
Twist Bioscience
TWST
$5.7B
| $8.46M | 0.04% |
229,609
-109,317
| -32% | -$2.53M |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q4 2023 Portfolio in Review
As of Q4 2023, Rafferty Asset Management held 1,113 positions worth $23.7B, up 39% from $17B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Rafferty Asset Management deployed $3.87B of net new capital in Q4 2023, opening 41 new positions and adding to 800 existing holdings. Its largest new stake was Splunk Inc: 70,916 shares worth $10.8M.
By sector, the portfolio is most concentrated in Technology at 40% of assets, down from 43% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Texas Instruments, an estimated $64.2M trimmed.
- Rafferty Asset Management's largest Q4 2023 buy was Splunk Inc: 70,916 shares worth $10.8M.
- Rafferty Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q4 2023, an estimated $1.89B increase.
- Rafferty Asset Management's biggest Q4 2023 reduction was Texas Instruments, cutting an estimated $64.2M.
- Rafferty Asset Management fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $17.8M.
- Rafferty Asset Management's ten largest holdings make up 42% of its $23.7B portfolio in Q4 2023.
- Rafferty Asset Management opened 41 new positions and closed 43 in Q4 2023.
- Rafferty Asset Management's portfolio value rose 39% quarter-over-quarter to $23.7B.
Based on Rafferty Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.